Moleculin Biotech, Inc. Business Finance Contracts & Agreements
39 Contracts & Agreements
- Assignment Agreements (1 contract)
- Escrow Agreements (1)
- Purchase Agreements (7)
- Registration Rights Agreements (3)
- Stock Agreements (2)
- Subscription Agreements (2)
- Underwriting Agreements (5)
- Warrant Agreements (18)
- Form of Warrant Amendment Agreement (Filed With SEC on August 16, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on August 15, 2024)
- Form of Placement Agent Warrant (Filed With SEC on August 15, 2024)
- Form of Series B Common Warrant (Filed With SEC on August 15, 2024)
- Form of Series A Common Warrant (Filed With SEC on August 15, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on August 15, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on December 21, 2023)
- Form of Common Warrant (Filed With SEC on December 21, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on December 21, 2023)
- Assignment Consent Letter by and between WPD Pharmaceuticals Sp. z o.o and LPC Enterprises, LLC and Moleculin Biotech, Inc (Filed With SEC on December 27, 2021)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 25, 2021)
- PURCHASE AGREEMENT (Filed With SEC on June 25, 2021)
- MOLECULIN BIOTECH, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on June 25, 2021)
- Underwriting Agreement, dated February 3, 2021, by and between the Company and Oppenheimer & Co. Inc., as representative of the several Underwriters named therein (Filed With SEC on February 4, 2021)
- Registration Rights Agreement(LPC-Moleculin Biotech, Inc.) (Filed With SEC on November 12, 2020)
- Purchase Agreement (LPC-Moleculin Biotech, Inc.) (Filed With SEC on November 12, 2020)
- Form of Investor Subscription Agreement (Filed With SEC on February 6, 2020)
- Form of Placement Agent Warrant (Filed With SEC on February 6, 2020)
- Form of Warrant (Filed With SEC on February 6, 2020)
- Form of Subscription Agreement (Filed With SEC on April 24, 2019)
- Form of Placement Agent Warrant (Filed With SEC on April 24, 2019)
- Form of Warrant included in Unit (Filed With SEC on April 24, 2019)
- Form of Underwriter Warrant (Filed With SEC on March 28, 2019)
- Form of Warrant included in Unit (Filed With SEC on March 28, 2019)
- Underwriting Agreement, dated March 27, 2019, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on March 28, 2019)
- Registration Rights Agreement, dated as of October 4, 2018, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on October 5, 2018)
- Purchase Agreement, dated as of October 4, 2018, by and between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on October 5, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on June 21, 2018)
- Form of Warrant (Filed With SEC on June 21, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on February 16, 2018)
- Form of Warrant (Filed With SEC on February 16, 2018)
- SERIES [A/B/C] COMMON STOCK PURCHASE WARRANT moleculinbiOtech, inc. (Filed With SEC on February 9, 2017)
- 3,710,000 SHARES ofCommon Stock, 3,710,000SERIES A Warrants (EXERCISABLE FOR 1,855,000SHARES OF COMMON STOCK), 3,710,000SERIES b Warrants (EXERCISABLE FOR3,710,000 SHARES OF... (Filed With SEC on February 9, 2017)
- [FORM OF SERIESA/B/C WARRANT] SERIES[A/B/C] COMMON STOCK PURCHASE WARRANT moleculinbiOtech, inc. (Filed With SEC on February 7, 2017)
- ____________ SHARES ofCommon Stock, _____________SERIES A Warrants, _____________SERIES b Warrants, and_____________ SERIES c Warrants of MOLECULIN BIOTECH, INC. UNDERWRITING... (Filed With SEC on February 7, 2017)
- WARRANT AGENCYAGREEMENT (Filed With SEC on January 18, 2017)
- ESCROW DEPOSIT AGREEMENT (Filed With SEC on April 15, 2016)
- MOLECULIN BIOTECH, INC. 2015 STOCK PLAN (Filed With SEC on March 22, 2016)
- Moleculin Biotech UNDERWRITING AGREEMENT dated [ยท],2016 Bonwick Capital Partners, LLC (Filed With SEC on March 22, 2016)
